The observed downregulation of S-adenosyl methionine (SAM), a potential allosteric regulator of CBS, in AD patient samples [37] offers a compelling avenue for further research, as does the documented post-translational modification of crucial enzymes via sulfhydration, a process mediated by H2S [38]. The gene discussed is CBS; the disease is Alzheimer disease.